Kathy Galante | Investor Relations |
Glenn Sblendorio | President and Chief Executive Officer |
David Guyer | Executive Chairman |
Dave Carroll | Chief Financial Officer |
Pravin Dugel | Chief Strategy and Business Officer |
Kourous Rezaei | Chief Medical Officer |
Abraham Scaria | Chief Scientific Officer |
Keith Westby | Chief Operating Officer |
David Nierengarten | Wedbush Securities |
Good day and welcome to the IVERIC bio First Quarter 2020 Results Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Kathy Galante. Please go ahead.
Good morning and welcome to IVERIC bio’s conference call.